BridgeMD
Respiratory rehabilitation in patients with ILD
EU CTIS ID: 2024-519541-30-00
What this study is testing
To compare the level of oxygenation achieved during muscle training with conventional oxygen therapy systems (nasal cannula) and high-flow systems.
- Therapeutic confirmatory (Phase III)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Age > 30 years
- Diagnosis of Interstitial Lung Disease (ILD) according to national and international guidelines
- Signed informed consent form (Annex 1)
You likely can't join if
- Participation in a Respiratory Rehabilitation (RR) program (including training) in the last 6 months
- Intolerance to the high-flow oxygen administration system; while no cases have been reported to date (Frat et al, New Engl J of Med 2015; 372: 2185-96; Stephan et al, JAMA 2015; 313: 2331-39)
- Respiratory diseases other than ILD
- Severe cardiac, neuromuscular, anemia, vascular diseases, or other serious comorbidities (primarily severe pulmonary hypertension per SEPAR Guidelines 2017)
- Osteoarticular diseases that hinder exercise performance
- Terminal illness (inability to perform exercises or treatment with opioids)
See the full eligibility criteria
- Age > 30 years
- Diagnosis of Interstitial Lung Disease (ILD) according to national and international guidelines
- Signed informed consent form (Annex 1)
- Participation in a Respiratory Rehabilitation (RR) program (including training) in the last 6 months
- Intolerance to the high-flow oxygen administration system; while no cases have been reported to date (Frat et al, New Engl J of Med 2015; 372: 2185-96; Stephan et al, JAMA 2015; 313: 2331-39)
- Respiratory diseases other than ILD
- Severe cardiac, neuromuscular, anemia, vascular diseases, or other serious comorbidities (primarily severe pulmonary hypertension per SEPAR Guidelines 2017)
- Osteoarticular diseases that hinder exercise performance
- Terminal illness (inability to perform exercises or treatment with opioids)
- Life expectancy < 6 months
- Cognitive disorders that prevent active participation
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65+ years, 18-64 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.